BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 10225659)

  • 41. Consequences of direct genetic testing for germline mutations in the clinical management of families with multiple endocrine neoplasia, type II.
    Neumann HP; Eng C; Mulligan LM; Glavac D; Zäuner I; Ponder BA; Crossey PA; Maher ER; Brauch H
    JAMA; 1995 Oct; 274(14):1149-51. PubMed ID: 7563486
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Detection of RET proto-oncogene point mutations in paraffin-embedded pheochromocytoma specimens by nonradioactive single-strand conformation polymorphism analysis and direct sequencing.
    Komminoth P; Kunz E; Hiort O; Schröder S; Matias-Guiu X; Christiansen G; Roth J; Heitz PU
    Am J Pathol; 1994 Oct; 145(4):922-9. PubMed ID: 7943181
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Sparing surgery for bilateral pheochromocytoma].
    Shimoyama T; Saito J; Ito Y; Soyama A; Ito H; Nishikawa T; Kakuta Y; Nagata M; Yamaguchi K; Iizuka T
    Nihon Naika Gakkai Zasshi; 2004 Nov; 93(11):2416-8. PubMed ID: 15624479
    [No Abstract]   [Full Text] [Related]  

  • 44. Germ line mutation in the RET proto-oncogene associated with familial multiple endocrine neoplasia type 2B: a case report.
    Ishida O; Zeki K; Morimoto I; Yamamoto S; Fujihira T; Eto S
    Jpn J Clin Oncol; 1995 Jun; 25(3):104-8. PubMed ID: 7596047
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Distinction between sporadic and hereditary medullary thyroid carcinoma (MTC) by mutation analysis of the RET proto-oncogene. "Study Group Multiple Endocrine Neoplasia Austria (SMENA)".
    Fink M; Weinhüsel A; Niederle B; Haas OA
    Int J Cancer; 1996 Aug; 69(4):312-6. PubMed ID: 8797874
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [A case of multiple endocrine neoplasia type 2A (MEN2A) with a mutation in the RET gene].
    Ishizu K; Shiraishi K; Kawamura H; Naito K; Takahashi T; Yoshimura K; Tangoku A; Shirahama S
    Hinyokika Kiyo; 1999 Jun; 45(6):407-10. PubMed ID: 10442282
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A family of multiple endocrine neoplasia type 2A with the RET proto-oncogene mutation in codon 618 (Cys-->Arg).
    Nakao A; Naomoto Y; Kataoka M; Haisa M; Kataoka K; Saitoh S; Fujiwara T; Yamatsuji T; Shigemitsu K; Umeoka T; Isozaki H; Futami H; Yamaguchi K; Tanaka N
    Jpn J Clin Oncol; 2001 Apr; 31(4):157-61. PubMed ID: 11386462
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [A comparison of clinical characteristics between 2 pedigrees of multiple endocrine neoplasia type 2A with different RET mutations].
    Weng Y; Xue SN; Zhang SL; Cheng H; Yan L
    Zhonghua Nei Ke Za Zhi; 2018 Feb; 57(2):134-137. PubMed ID: 29397600
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Very early detection of RET proto-oncogene mutation is crucial for preventive thyroidectomy in multiple endocrine neoplasia type 2 children: presence of C-cell malignant disease in asymptomatic carriers.
    Sanso GE; Domene HM; Garcia R; Pusiol E; de M; Roque M; Ring A; Perinetti H; Elsner B; Iorcansky S; Barontini M
    Cancer; 2002 Jan; 94(2):323-30. PubMed ID: 11900218
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Analysis of RET proto-oncogene abnormalities in patients with MEN 2A, MEN 2B, familial or sporadic medullary thyroid carcinoma.
    Chiefari E; Russo D; Giuffrida D; Zampa GA; Meringolo D; Arturi F; Chiodini I; Bianchi D; Attard M; Trischitta V; Bruno R; Giannasio P; Pontecorvi A; Filetti S
    J Endocrinol Invest; 1998 Jun; 21(6):358-64. PubMed ID: 9699127
    [TBL] [Abstract][Full Text] [Related]  

  • 51. RET mutation screening in sporadic pheochromocytoma.
    Arnold A
    J Clin Endocrinol Metab; 1996 Jan; 81(1):430. PubMed ID: 8550789
    [No Abstract]   [Full Text] [Related]  

  • 52. Cancers connected with mutations in RET proto-oncogene.
    Altanerová V
    Neoplasma; 2001; 48(5):325-31. PubMed ID: 11845976
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mutations of the ret protooncogene in German multiple endocrine neoplasia families: relation between genotype and phenotype. German Medullary Thyroid Carcinoma Study Group.
    Frank-Raue K; Höppner W; Frilling A; Kotzerke J; Dralle H; Haase R; Mann K; Seif F; Kirchner R; Rendl J; Deckart HF; Ritter MM; Hampel R; Klempa J; Scholz GH; Raue F
    J Clin Endocrinol Metab; 1996 May; 81(5):1780-3. PubMed ID: 8626834
    [TBL] [Abstract][Full Text] [Related]  

  • 54. RET proto-oncogene mutations and rearrangements in endocrine diseases.
    Lloyd RV
    Am J Pathol; 1995 Dec; 147(6):1539-44. PubMed ID: 7495277
    [No Abstract]   [Full Text] [Related]  

  • 55. Novel germline mutation in the transmembrane region of RET gene close to Cys634Ser mutation associated with MEN 2A syndrome.
    Poturnajova M; Altanerova V; Kostalova L; Breza J; Altaner C
    J Mol Med (Berl); 2005 Apr; 83(4):287-95. PubMed ID: 15592804
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A de novo mutation of the RET proto-oncogene in a patient with MEN 2A.
    Mulligan LM; Eng C; Healey CS; Ponder MA; Feldman GL; Li P; Jackson CE; Ponder BA
    Hum Mol Genet; 1994 Jun; 3(6):1007-8. PubMed ID: 7951212
    [No Abstract]   [Full Text] [Related]  

  • 57. Risk and penetrance of primary hyperparathyroidism in multiple endocrine neoplasia type 2A families with mutations at codon 634 of the RET proto-oncogene. Groupe D'etude des Tumeurs à Calcitonine.
    Schuffenecker I; Virally-Monod M; Brohet R; Goldgar D; Conte-Devolx B; Leclerc L; Chabre O; Boneu A; Caron J; Houdent C; Modigliani E; Rohmer V; Schlumberger M; Eng C; Guillausseau PJ; Lenoir GM
    J Clin Endocrinol Metab; 1998 Feb; 83(2):487-91. PubMed ID: 9467562
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Somatic and MEN 2A de novo mutations identified in the RET proto-oncogene by screening of sporadic MTC:s.
    Zedenius J; Wallin G; Hamberger B; Nordenskjöld M; Weber G; Larsson C
    Hum Mol Genet; 1994 Aug; 3(8):1259-62. PubMed ID: 7987299
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mutations of codon 918 in the RET proto-oncogene correlate to poor prognosis in sporadic medullary thyroid carcinomas.
    Zedenius J; Larsson C; Bergholm U; Bovée J; Svensson A; Hallengren B; Grimelius L; Bäckdahl M; Weber G; Wallin G
    J Clin Endocrinol Metab; 1995 Oct; 80(10):3088-90. PubMed ID: 7559902
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Genetic basis of endocrine disease: multiple endocrine neoplasia type 2.
    Mulligan LM; Ponder BA
    J Clin Endocrinol Metab; 1995 Jul; 80(7):1989-95. PubMed ID: 7608246
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.